Literature DB >> 2214829

Long-term results of the Belsey Mark IV antireflux operation in relation to the severity of esophagitis.

F D Salama1, G Lamont.   

Abstract

A retrospective analysis of the results of the Belsey Mark IV operation has been conducted, relating these to the degree of esophagitis present preoperatively. Analysis of 89 patients showed a 91.7% success rate in patients without esophagitis. Good results diminished steadily as the severity of esophagitis increased, giving 76.5%, 75%, 66.7%, and 50% success rates for first-, second-, third-, and fourth-degree esophagitis, respectively. We believe that shortening of the esophagus is an important factor in this. Shortening is obvious in third- and fourth-degree esophagitis but subtle in first- and second-degree esophagitis. We conclude that the Belsey operation is adequate for patients without esophagitis, but for patients with any degree of esophagitis more effective reflux control is needed.

Entities:  

Mesh:

Year:  1990        PMID: 2214829

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

2.  Three-dimensional imaging of the lower esophageal sphincter in gastroesophageal reflux disease.

Authors:  H J Stein; T R DeMeester; R Naspetti; J Jamieson; R E Perry
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

3.  Prospective evaluation of 24 hour ambulatory pH metry in Belsey Mark IV antireflux surgery.

Authors:  J M Horbach; A A Masclee; C B Lamers; H G Gooszen
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

4.  Laparoscopic Nissen fundoplication is less expensive than open Belsey Mark IV.

Authors:  W S Laycock; M Oddsdottir; A Franco; K Mansour; J G Hunter
Journal:  Surg Endosc       Date:  1995-04       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.